Skip to search formSkip to main contentSkip to account menu

asimadoline

Known as: N-methyl-N--(1-phenyl-2-(3-hydroxypyrrolidin-1-yl)ethyl)-2,2-diphenylacetamide hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Opioids are the most effective drugs for the treatment of severe pain, but they also cause addiction and overdose deaths, which… 
Highly Cited
2008
Highly Cited
2008
Background  In models of irritable bowel syndrome (IBS), asimadoline, a kappa‐opioid agonist, improves pain and abnormal bowel… 
Review
2008
Review
2008
Abstract  Asimadoline is a potent κ‐opioid receptor agonist with a diaryl acetamide structure. It has high affinity for the… 
Highly Cited
2008
Highly Cited
2008
Salvinorin (Sal) A is a naturally occurring, selective κ opioid receptor (KOPR) agonist with a short duration of action in vivo… 
Highly Cited
2006
Highly Cited
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Highly Cited
2004
Highly Cited
2004
Background : Visceral hypersensitivity plays a major role in irritable bowel syndrome pathophysiology. Opioid κ receptors on… 
Highly Cited
2003
Highly Cited
2003
To compare the effects of the kappa-opioid agonist asimadoline and placebo on visceral sensation and gastrointestinal (GI) motor… 
Highly Cited
1999
Highly Cited
1999
Studies with knockout mice lacking mdr1a P‐glycoprotein (P‐gp) have previously shown that blood‐brain barrier P‐gp is important… 
1999
1999
We have previously shown that kappa‐opioids have antiarthritic properties. In this study, using two differently acting drugs (the…